TeamViewer (TMV) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
6 May, 2026Executive summary
Q1 2026 revenue was €183.2m, broadly stable year-over-year at -0.4% constant currency, with ARR at €737.3m (+0.2% cc yoy).
Enterprise ARR grew 8% cc year-over-year, offsetting SMB softness and one-off churn effects.
Adjusted EBITDA increased 2% year-over-year to €83.0m, with a margin of 45.3%.
TeamViewer ONE adoption accelerated, with ARR doubling quarter-over-quarter and average daily billings doubling since December 2025.
AI adoption is scaling rapidly, with over 1.4 million cumulative AI sessions and strong customer traction.
Financial highlights
ARR reached €737.3m (+0.2% cc yoy); revenue was €183.2m (-0.4% cc yoy), both broadly flat year-over-year.
Adjusted EBITDA was €83.0m (+2% yoy), margin 45.3% (+2pp yoy).
Net income increased 15% year-over-year to €34.2m; adjusted EPS was €0.29.
Levered Free Cash Flow (FCFE) was €23.8m, down 47% year-over-year due to timing and one-off legal payments.
Net debt reduced to €870.0m; net leverage ratio improved to 2.5x.
Outlook and guidance
Full-year 2026 guidance reaffirmed: constant currency revenue growth of 0–3% versus 2025 and adjusted EBITDA margin around 43%.
ARR growth acceleration expected in H2 2026 as temporary headwinds subside.
SMB churn to remain elevated in Q2, then stabilize.
Levered free cash flow expected between €190m and €210m for 2026.
Currency fluctuations, especially USD, expected to negatively impact reported revenue by 2.5 percentage points.
Latest events from TeamViewer
- 5% revenue and 8% EBITDA growth in 2025; 2026 outlook cautious with 0–3% growth target.TMV
Q4 202510 Feb 2026 - Q2 2024 delivered strong growth, high margins, and reaffirmed full-year guidance.TMV
Q2 20242 Feb 2026 - Enterprise momentum and cost discipline drove strong Q3 growth and profitability.TMV
Q3 202416 Jan 2026 - $720M deal creates a DEX leader, targeting double-digit growth and global expansion by 2027.TMV
M&A Announcement11 Jan 2026 - FY 2024 exceeded guidance with strong Enterprise growth, 1E integration, and margin expansion.TMV
Q4 202416 Dec 2025 - Enterprise ARR up 21%, revenue and EBITDA both rise 7% and 20% year-over-year, outlook confirmed.TMV
Q1 202519 Nov 2025 - Q2 revenue up 6% and adjusted EBITDA up 17%, driven by enterprise gains and new product launches.TMV
Q2 202516 Nov 2025 - Q3 delivered 4% growth and 46% margin, but 1E weakness led to lower ARR guidance for 2025.TMV
Q3 202522 Oct 2025